한글목차

세계 동물 통증 관리 시장 규모는 예측 기간 동안 6.44%의 연평균 복합 성장률(CAGR)로 견조한 성장세를 보일 것으로 예상됩니다. 동물 질병의 보편화, 반려동물 사육률 증가, 반려동물 인구 증가 등의 요인이 시장 성장의 원동력이 되고 있습니다.

지역별로는 북미 시장이 2022년 가장 큰 점유율을 차지할 것으로 보입니다. 이는 이 지역의 반려동물 사육 수 증가와 신경질환 증가에 따른 것으로 분석됩니다. 유럽 시장은 전염병 유행 등으로 인해 통증 관리 품목에 대한 관심이 높아지면서 세계 2위 시장으로 부상했습니다. 아시아태평양의 성장은 중국, 인도, 한국 등 경제가 빠르게 발전하고 있는 국가들의 존재에 기인합니다. 이 지역은 신규 시장 진출기업들에게 많은 성장 기회를 제공합니다. 반려동물에 대한 선택의 폭이 넓어지고 반려동물의 개체수가 증가하면서 시장 발전을 촉진하는 요인이 되고 있습니다.

세계 동물용 통증 관리 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 조사 방법

제4장 시장 역학

• 개요
• 성장 촉진요인
• 성장 억제요인
• 기회

제5장 시장 영향요인 분석

• 밸류체인 분석
• Porter's Five Forces 모델
• COVID-19의 영향

제6장 세계의 동물용 통증 관리 시장 : 제품별

• 개요
• 약제
  • 비스테로이드성 항염증제(NSAIDS)
  • 오피오이드
  • 국소 마취제
  • 기타
• 디바이스
  • 레이저 치료기
  • TENS 유닛

제7장 세계의 동물용 통증 관리 시장 : 용도별

• 개요
• 관절통
• 수술후 통증
• 암성 통증
• 기타

제8장 세계의 동물용 통증 관리 시장 : 동물 유형별

• 개요
• 반려동물
  • 개
  • 고양이
  • 말
  • 기타
• 가축
  • 소
  • 돼지
  • 가금류
  • 기타

제9장 세계의 동물용 통증 관리 시장 : 유통 채널별

• 개요
• 동물 병원 및 진료소
• 약국
• 온라인 약국

제10장 세계의 동물용 통증 관리 시장 : 지역별

• 개요
• 북미
• 유럽
• 아시아태평양
• 중동 및 아프리카
• 남미

제11장 경쟁 구도

• 경쟁 벤치마킹
• 주요 성장 전략
• 개발 건수 기준 리더
• 주요 개발 분석
• 주요 전개와 성장 전략
• 재무 매트릭스

제12장 기업 개요

• BOEHRINGER INGELHEIM
• VETOQUINOL
• CEVA ANIMAL HEALTH, LLC
• CHANELLE PHARMA
• ELANCO
• DECHRA PHARMACEUTICALS PLC
• ZOETIS
• MERCK & CO., INC
• ASSISI ANIMAL HEALTH
• ELTECH K-LASER

제13장 부록

영문목차

Market Overview

Global Veterinary Pain Management market is projected to register a healthy CAGR of 6.44% during the reviewt period. Developing commonness of painful and fiery illnesses in creatures and ascend in sidekick creature proprietorship and huge pet populace are driving market development.

The ascent in sidekick creature possession and enormous animals' populace, ascend in pet protection with a flood in creature wellbeing consumption, and developing predominance of creature illnesses are supposed to drive the development of the worldwide veterinary pain management market.

The rising number of pet people across the globe is supposed to help market development over the forecast period. For example, as per the American Culture for the Anticipation of Mercilessness to Creatures (ASPCA), around 6.5 million sidekick creatures enter the US creature shields cross country every year. Besides, as expressed by the American Pet Items Affiliation 2015 to 2016 (APPA) study, roughly 44% of all families in the US had a canine, and 35% had a feline.

Market Segmentation

Devices and drugs are included in the product-based segmentation of the worldwide veterinary pain treatment market. The market has been further divided into categories based on pharmaceuticals, including opioids, local anesthetics, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. The NSAIDs category has been further divided into categories such as etodolac, meloxicam, and others.

Joint pain, postoperative pain, cancer, and other conditions are among the applications used to segment the worldwide veterinary pain management market.

Companion and farm animals are the two animal types used to segment the worldwide veterinarian pain management market. Dogs, cats, horses, and other animals have been further subdivided under companion animals. The market has been further subdivided into cattle, pigs, poultry, and other livestock-based animals.

The global veterinary pain management market segmentation is based on a distribution channel that includes veterinary hospitals & clinics, pharmacies, and online pharmacies.

Regional Insights

The North America clear aligners market represented the biggest market share in 2022. This is because of the rising pet populace and the rising number of neurological sicknesses in the region. Besides, the presence of numerous observable players like Zoetis (New Jersey, US), Merck and Co., Inc. (New Jersey, US), and Assisi Creature Wellbeing (New Mexico, US) in this region is the significant driving variable of the market in the North America.

Europe Veterinary Pain Management market represents the second-largest market owing to the rising pervasiveness of contagious creature sicknesses and expanded center around the wellbeing and prosperity of creatures is driving the interest in pain management items.

The Asia-Pacific Veterinary Pain Management market expansion is attributed to the presence of quickly creating economies of China, India, and South Korea. The region gives numerous valuable chances to market players to develop. The expanded pet selections and development in the number of inhabitants in sidekick creatures is supposed to drive the market development.

The Middle East and Africa region has less monetary turns of events and very low pay because of which the region represents the least market share yet is supposed to develop with the to further developing veterinary medical care offices and extension of the working-class populace in these regions.

Major Players

Companies such as Boehringer Ingelheim (Ingelheim am Rhein, Germany), Vetoquinol (Lure, France), Ceva Animal Health, LLC (Libourne, France), Dechra Pharmaceuticals PLC (Northwich, UK), Zoetis (New Jersey, US), Merck & Co., Inc. (New Jersey, US), Assisi Animal Health(New Mexico, US), Eltech K-Laser (Treviso, Italy), Chanelle Pharma (Galway, Ireland), and Elanco (Indiana, US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 GROWING PREVALENCE OF PAINFUL AND INFLAMMATORY DISEASES IN ANIMALS
  • 4.2.2 RISE IN COMPANION ANIMAL OWNERSHIP & LARGE PET POPULATION
  • 4.2.3 RISE IN PET INSURANCE WITH GROWING ANIMAL HEALTH EXPENDITURE
• 4.3 RESTRAINTS
  • 4.3.1 LACK OF AWARENESS REGARDING ANIMAL HEALTH
  • 4.3.2 UNAFFORDABILITY OF VETERINARY SERVICES IN UNDERDEVELOPED AND DEVELOPING REGIONS
• 4.4 OPPORTUNITIES
  • 4.4.1 RISING INITIATIVES BY THE GOVERNMENT AND OTHER ORGANIZATIONS

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D & DESIGNING
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE VETERINARY PAIN MANAGEMENT MARKET
  • 5.3.1 IMPACT SUPPLY CHAIN DISRUPTIONS
  • 5.3.2 IMPACT ON VETERINARY VISITS AND PROCEDURES
  • 5.3.1 IMPACT ON ADAPTATION TO NEW PRACTICES AND TECHNOLOGIES

6 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY PRODUCT

• 6.1 OVERVIEW
• 6.2 MEDICATION
  • 6.2.1 NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
    • 6.2.1.1.1 MELOXICAM
    • 6.2.1.2 ETODOLAC
    • 6.2.1.3 OTHERS
  • 6.2.2 OPIOIDS
  • 6.2.3 LOCAL ANESTHETICS
  • 6.2.4 OTHERS
• 6.3 DEVICES
  • 6.3.1 LASER THERAPY DEVICES
  • 6.3.2 TENS UNITS

7 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 JOINT PAIN
• 7.3 POSTOPERATIVE PAIN
• 7.4 CANCER
• 7.5 OTHERS

8 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY ANIMAL TYPE

• 8.1 OVERVIEW
• 8.2 COMPANION ANIMALS
  • 8.2.1 DOGS
  • 8.2.2 CATS
  • 8.2.3 HORSES
  • 8.2.4 OTHERS
• 8.3 LIVESTOCK ANIMALS
  • 8.3.1 CATTLE
  • 8.3.2 PIGS
  • 8.3.3 POULTRY
  • 8.3.4 OTHERS

9 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY DISTRIBUTION CHANNEL

• 9.1 OVERVIEW
• 9.2 VETERINARY HOSPITALS & CLINICS
• 9.3 PHARMACIES
• 9.4 ONLINE PHARMACIES

10 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY REGION

• 10.1 OVERVIEW
• 10.2 NORTH AMERICA
  • 10.2.1 US
  • 10.2.2 CANADA
• 10.3 EUROPE
  • 10.3.1 GERMANY
  • 10.3.2 UK
  • 10.3.3 FRANCE
  • 10.3.4 ITALY
  • 10.3.5 SPAIN
  • 10.3.6 REST OF EUROPE
• 10.4 ASIA-PACIFIC
  • 10.4.1 CHINA
  • 10.4.2 JAPAN
  • 10.4.3 INDIA
  • 10.4.4 SOUTH KOREA
  • 10.4.5 AUSTRALIA
  • 10.4.6 REST OF ASIA-PACIFIC
• 10.5 REST OF THE WORLD
  • 10.5.1 LATIN AMERICA
  • 10.5.2 MIDDLE EAST
  • 10.5.3 AFRICA
• 11.1 OVERVIEW
• 11.2 COMPETITIVE BENCHMARKING
• 11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
• 11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
• 11.5 KEY DEVELOPMENT ANALYSIS
• 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 11.6.1 PRODUCT APPROVAL AND LAUNCH
  • 11.6.2 EXPANSION
  • 11.6.3 ACQUISITION
• 11.7 FINANCIAL MATRIX
  • 11.7.1 SALES (USD MILLION), 2022
  • 11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

12 COMPANY PROFILES

• 12.1 BOEHRINGER INGELHEIM
  • 12.1.1 COMPANY OVERVIEW
  • 12.1.2 FINANCIAL OVERVIEW
  • 12.1.3 PRODUCTS OFFERED
  • 12.1.4 KEY DEVELOPMENTS
  • 12.1.5 SWOT ANALYSIS
  • 12.1.6 KEY STRATEGIES
• 12.2 VETOQUINOL
  • 12.2.1 COMPANY OVERVIEW
  • 12.2.2 FINANCIAL OVERVIEW
  • 12.2.3 PRODUCTS OFFERED
  • 12.2.4 KEY DEVELOPMENTS
  • 12.2.5 SWOT ANALYSIS
  • 12.2.6 KEY STRATEGIES
• 12.3 CEVA ANIMAL HEALTH, LLC
  • 12.3.1 COMPANY OVERVIEWS
  • 12.3.2 FINANCIAL OVERVIEW
  • 12.3.3 PRODUCTS OFFERED
  • 12.3.4 KEY DEVELOPMENTS
  • 12.3.5 KEY STRATEGIES
• 12.4 CHANELLE PHARMA
  • 12.4.1 COMPANY OVERVIEW
  • 12.4.2 FINANCIAL OVERVIEW
  • 12.4.3 PRODUCTS OFFERED
  • 12.4.4 KEY DEVELOPMENTS
  • 12.4.5 KEY STRATEGIES
• 12.5 ELANCO
  • 12.5.1 COMPANY OVERVIEW
  • 12.5.2 FINANCIAL OVERVIEW
  • 12.5.3 PRODUCTS OFFERED
  • 12.5.4 KEY DEVELOPMENTS
  • 12.5.5 SWOT ANALYSIS
  • 12.5.6 KEY STRATEGIES
• 12.6 DECHRA PHARMACEUTICALS PLC
  • 12.6.1 COMPANY OVERVIEWS
  • 12.6.2 FINANCIAL OVERVIEW
  • 12.6.3 PRODUCTS OFFERED
  • 12.6.4 KEY DEVELOPMENTS
  • 12.6.5 KEY STRATEGIES
• 12.7 ZOETIS
  • 12.7.1 COMPANY OVERVIEW
  • 12.7.2 FINANCIAL OVERVIEW
  • 12.7.3 PRODUCTS OFFERED
  • 12.7.4 KEY DEVELOPMENTS
  • 12.7.5 SWOT ANALYSIS
  • 12.7.6 KEY STRATEGIES
• 12.8 MERCK & CO., INC
  • 12.8.1 COMPANY OVERVIEW
  • 12.8.2 FINANCIAL OVERVIEW
  • 12.8.3 PRODUCTS OFFERED
  • 12.8.4 KEY DEVELOPMENTS
  • 12.8.5 SWOT ANALYSIS
  • 12.8.6 KEY STRATEGIES
• 12.9 ASSISI ANIMAL HEALTH
  • 12.9.1 COMPANY OVERVIEW
  • 12.9.2 FINANCIAL OVERVIEW
  • 12.9.3 PRODUCTS OFFERED
  • 12.9.4 KEY DEVELOPMENTS
  • 12.9.5 KEY STRATEGIES
• 12.10 ELTECH K-LASER
  • 12.10.1 COMPANY OVERVIEW
  • 12.10.2 FINANCIAL OVERVIEW
  • 12.10.3 PRODUCTS OFFERED
  • 12.10.4 KEY DEVELOPMENTS
  • 12.10.5 KEY STRATEGIES

13 APPENDIX

• 13.1 REFERENCES
• 13.2 RELATED REPORTS